Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy

@article{Zillich2005CaringFP,
  title={Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy},
  author={Alan J. Zillich and Joseph J. Saseen and Renee M Dehart and Peter Dumo and Darren W. Grabe and Cheryl Gilmartin and David M. Hachey and Joanna Q Hudson and Maria C. Pruchnicki and Melanie S Joy},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year={2005},
  volume={25}
}
  • A. Zillich, J. Saseen, +7 authors M. Joy
  • Published 1 January 2005
  • Medicine
  • Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
An increasing number of patients are developing chronic kidney disease (CKD). Appropriate care for patients with CKD must occur in the earliest stages, preferably before CKD progresses to more severe stages. Therefore, recognition and treatment of CKD and its associated complications must occur in primary care settings. Patients with CKD often have comorbid conditions such as diabetes mellitus, hypertension, and dyslipidemia, creating specific considerations when treating these diseases. Also… 
View on Wiley
accp.com
30 Citations
Highly Influential Citations
1
Background Citations
12

30 Citations

Citation Type

Citation Type

Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations
Anemia is an underrecognized but characteristic feature of chronic kidney disease (CKD), associated with significant cardiovascular morbidity, hospitalization, and mortality. Since their inception…
Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review
TLDR
Few high-quality trials addressing the benefit and impact of clinical pharmacy services in CKD and ESRD patients have been published, however, all available studies reported some positive impact resulting from clinical pharmacist involvement, including various investigated outcome measures that could be improved.
Standards of clinical practice for renal pharmacists.
TLDR
A systematic review of 8 controlled trials involving patients with CKD showed that clinical pharmacist interventions improved management of anemia, blood pressure, and lipids, as well as calcium and phosphate parameters.
New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management
TLDR
Opportunities are growing to include pharmacists as integral members of CKD and dialysis healthcare teams to reduce MRPs, increase medication adherence and improve patient outcomes.
Potentially preventable hospitalization as a complication of CKD: a cohort study.
TLDR
The findings suggest that future studies seeking to determine how to prevent ambulatory care-sensitive conditions in people with CKD should target remote dwellers and those with comorbid conditions such as concomitant heart failure and liver disease.
Community pharmacist targeted screening for chronic kidney disease
TLDR
This study evaluated pharmacists’ application of the CKD Clinical Pathway in the screening and identification of patients with CKD, particularly those with previously unrecognized CKD.
Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study
TLDR
A pilot study on the use of PoCT by community pharmacists to help identify chronic kidney disease (CKD) was conducted, to determine the potential recruitment rate and gauge the potential number of patients identified with CKD through this process, to inform a full-scale clinical trial.
Multidisciplinary clinic for patients with newly diagnosed chronic kidney disease.
  • Shuli Lim, J. Lee, S. Subramanian, P. How
  • Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2012
TLDR
In Singapore, the prevalence of CKD has steadily increased over the years, and the number of patients diagnosed with the disease has increased significantly.
Improving the Management of Chronic Kidney Disease in Uruguay: A National Renal Healthcare Program
TLDR
Control improved in patients under the care of a PCP according to years of enrollment and the impact of the NC and renin-angiotensin-aldosterone system blockers highlight the best management of CKD patients in both groups.
Cognitive Pharmacy Services at a Pediatric Nephrology and Hypertension Clinic
TLDR
Pediatric cognitive pharmacy services to patients at the UNC pediatric nephrology clinic were feasible, which improved the quality of services and promoted better outcomes for these complex patients.
...
1
2
3
...

References

SHOWING 1-10 OF 183 REFERENCES
Patterns of care for patients with chronic kidney disease in the United States: dying for improvement.
  • W. Owen
  • Medicine, Biology
    Journal of the American Society of Nephrology : JASN
  • 2003
TLDR
The findings confirm the urgent need for improvement in healthcare delivery for CKD patient in the United States and confirm the wide international variability in modality treatment selection.
Health care resource utilization and the impact of anemia management in patients with chronic kidney disease.
TLDR
Although patients consumed significant amounts of resources during the 12 months before dialysis initiation, many were not using expected resources for the appropriate management of CKD.
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease
TLDR
The purpose of the Executive Summary is to provide a "stand-alone" summary of the background, scope, methods, and key recommendations, as well as the complete text of the guideline statements.
Standards of Medical Care for Patients With Diabetes Mellitus
  • Medicine
    Diabetes Care
  • 1998
TLDR
These standards of diabetes care seek to provide basic medical care for people with diabetes.
Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?
  • A. Levey
  • Medicine, Biology
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 1998
TLDR
This month’s issue of the American Journal of Kidney Diseases contains a summary of the report of the Task Force, including a description of the process used to answer this question, as well as recommendations for clinical practice and clinical research.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
  • Kdoqi Disclaimer
  • Medicine
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2002
TLDR
Initiation of treatment for cardiovascular risk factors at earlier stages of chronic kidney disease should be effective in reducing cardiovascular disease events both before and after the onset of kidney failure.
K/DOQI clinical practice guidelines for chronic kidney disease
TLDR
This guideline contains brief reference to diagnosis and clinical interventions and can serve as a "road map" linking other clinical practice guidelines and pointing out where other guidelines need to be developed.
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.
Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study.
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency.
TLDR
Given the high burden of disease in these patients, beta-blockers and ACE inhibitors should be used to control hypertension and/or for cardioprotection, and the increased use of ASA and statins should be considered.
...
1
2
3
4
5
...